NeoPhore Limited, a small molecule neoantigen immuno-oncology company, has announced the completion of its £21.5m Series B financing, with a £6m financing...
Radiology services are becoming increasingly decentralised and personalised, offering a far more convenient pathway for diagnosis and treatment. A major...